文献速递生殖医学

玻璃化冻融整倍体囊胚移植后的临床、产科和围产结局与冷冻储存时长无关

Clinical, obstetric and perinatal outcomes after vitrified-warmed euploid blastocyst transfer are independent of cryo-storage duration.
PubMed 文献 · Reprod Biomed Online · 2021-10-08

该观察性研究纳入2013年5月至2020年3月一家私立体外受精中心的2688例玻璃化冻融整倍体单囊胚移植(1884名女性,年龄38±3岁),按冷冻储存时长分为≤60天至>1080天共7组。主要结局为每移植活产率,次要结局为流产率及产科和围产问题;校正混杂因素后各储存时长组结局相似。结论认为,即使囊胚玻璃化后储存超过3年,也不影响临床、产科和围产结局。

要点

  • 按冷冻储存时长≤60天至>1080天分为7组,每移植活产率在校正混杂因素后各组相似。
  • 未校正分析中91-180天、181-360天和361-720天组活产率低于≤60天组,主要因优质胚胎优先移植。
  • 次要结局(流产率及产科和围产问题)在各储存时长组间无差异。

核心结论

  • 囊胚玻璃化后冷冻储存时长即使超过3年,也不影响临床、产科和围产结局。

研究设计与样本

  • 观察性研究,纳入2013年5月至2020年3月一家私立体外受精中心的2688例玻璃化冻融整倍体单囊胚移植。
  • 共1884名女性,年龄38±3岁,均在接受非整倍体植入前遗传学检测后至少移植一次。
  • 按玻璃化至复温的冷冻储存时长分为7组:≤60天(n=646;对照组)、61-90天(n=599)、91-180天(n=679)、181-360天(n=405)、361-720天(n=144)、721-1080天(n=118)和>1080天(n=97)。
  • 主要结局为每移植活产率,次要结局为流产率及产科和围产问题;数据通过逻辑或线性回归校正混杂因素。

主要发现

  • ≤60天组活产率为49.4%(n=319/646),91-180天组为42.9%(n=291/679;P=0.017)、181-360天组为41.7%(n=169/405;P=0.016)、361-720天组为39.6%(n=57/144;P=0.034),均低于≤60天组。
  • 上述活产率差异主要由于整倍体囊胚较多时优质胚胎被优先移植,较低质量胚胎留待后续操作。
  • 校正混杂因素后的多因素比值比显示,所有冷冻储存时长组结果相似。
  • 所有次要结局在各冷冻储存时长组间均无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: The study aimed to retrospectively evaluate the impact of cryo-storage duration on clinical, obstetric and perinatal outcomes after vitrified-warmed euploid blastocyst transfer. DESIGN: This was an observational study including 2688 vitrified-warmed euploid single blastocyst transfers that was conducted at a private IVF centre between May 2013 and March 2020. It included a total of 1884 women (age 38 ± 3 years) undergoing at least one transfer after preimplantation genetic testing for aneuploidies. The euploid blastocysts transferred were clustered into seven groups according to the cryo-storage duration between vitrification and warming: ≤60 days (n = 646; control group), 61-90 days (n = 599), 91-180 days (n = 679), 181-360 days (n = 405), 361-720 days (n = 144), 721-1080 days (n = 118) and >1080 days (n = 97). The primary outcome was the live birth rate (LBR) per transfer. The secondary outcomes were miscarriage rate, obstetric and perinatal issues. The data were adjusted for confounders through logistic or linear regressions. RESULTS: A significantly lower LBR was reported for transfers performed within 91-180 days (n = 291/679, 42.9%; P = 0.017), 181-360 days (n = 169/405, 41.7%; P = 0.016) and 361-720 days (n = 57/144, 39.6%; P = 0.034) versus ≤60 days (n = 319/646, 49.4%). However, this was mainly due to top-quality embryos being transferred first when more euploid blastocysts were available, thereby leaving lower quality ones for subsequent procedures. Indeed, the multivariate odds ratios adjusted for confounders showed similar results across all cryo-storage duration clusters. No difference was reported also for all secondary outcomes. CONCLUSIONS: Cryo-storage duration even beyond 3 years from blastocyst vitrification does not affect clinical, obstetric and perinatal outcomes.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Cimadomo D, Fabozzi G, Dovere L, et al. Clinical, obstetric and perinatal outcomes after vitrified-warmed euploid blastocyst transfer are independent of cryo-storage duration. Reprod Biomed Online. 2021. PMID: 34862135. doi:10.1016/j.rbmo.2021.09.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。